Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dum

Showing results (171-180 of 202) with videos related to

Pageof 21
Sort By:
Cancers|December 17, 2024
Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 TumorsKristina Jansen, Lara Kornfeld, Maximilian Lennartz, et al.
International Journal of Immunopathology and Pharmacology|June 28, 2022
Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinomaSebastian Dwertmann Rico, Franziska Büscheck, David Dum, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Molecular Cancer Research : MCR|March 28, 2023
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial OrchestrationElena Bady, Katharina Möller, Tim Mandelkow, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotypeSeyma Büyücek, Magalie Lurati, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
Aging|September 19, 2019
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancerPatrick Lebok, Aurelia von Hassel, Jan Meiners, et al.
The American Journal of Surgical Pathology|August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor TypesNatalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
Plos One|April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumorsSeyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Virchows Archiv : an International Journal of Pathology|June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumorsViktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.
Pageof 21

Showing results (171-180 of 202) with videos related to

Sort By:
Pageof 21
Cancers|December 17, 2024
Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 TumorsKristina Jansen, Lara Kornfeld, Maximilian Lennartz, et al.
International Journal of Immunopathology and Pharmacology|June 28, 2022
Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinomaSebastian Dwertmann Rico, Franziska Büscheck, David Dum, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Molecular Cancer Research : MCR|March 28, 2023
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial OrchestrationElena Bady, Katharina Möller, Tim Mandelkow, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotypeSeyma Büyücek, Magalie Lurati, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
Aging|September 19, 2019
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancerPatrick Lebok, Aurelia von Hassel, Jan Meiners, et al.
The American Journal of Surgical Pathology|August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor TypesNatalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
Plos One|April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumorsSeyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Virchows Archiv : an International Journal of Pathology|June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumorsViktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.
Pageof 21